A Target worker says his manager told him to clock out for the day but refused to tell him why. The worker recorded his manager while questioning her decision to have him clock out. He posted the ...

A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma stem cells, impairing the cancer cells' ability to survive and grow.

The identification of a small molecule drug that can target the brain’s circadian clock proteins may prove effective for treating glioblastoma, the most common cancerous brain tumor in adults, ...

A new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in Phase 1 clinical trials. Credit: Issey Takahashi The identification of a small ...

LOS ANGELES — The identification of a small molecule drug that can target the brain’s circadian clock proteins may prove effective for treating glioblastoma, the most common cancerous brain tumor in ...

A Keck School of Medicine of USC-led research team has demonstrated that circadian clock proteins, which help to coordinate changes in the body’s functions over the course of a day, may play a key ...

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths globally. While chemotherapy, surgery, and liver transplants have helped some patients, targeted treatments for HCC ...